Taf4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83614
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human Taf4. Peptide sequence: AGAAGAGPAAPAEGAPGAAPEPPPAGRARPGGGGPQRPGPPSPRRPLVPA The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Taf4 Antibody
Western Blot: Taf4 Antibody [NBP2-83614]
Western Blot: Taf4 Antibody [NBP2-83614] - Host: Rabbit. Target Name: TAF4. Sample Tissue: Human HCT116 Whole Cell lysates. Antibody Dilution: 1ug/mlApplications for Taf4 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Taf4
Alternate Names
FLJ41943, TAF(II)130, TAF(II)135, TAF2C1TBP-associated factor 4, TAF2CRNA polymerase II TBP-associated factor subunit C, TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, TAF4A, TAFII130TAFII-130, TAFII135TAFII-135, TATA box binding protein (TBP)-associated factor, 135kD, TATA box binding protein (TBP)-associated factor, RNA polymerase II, C1, 130kD, Transcription initiation factor TFIID 130 kDa subunit, transcription initiation factor TFIID 135 kD subunit, transcription initiation factor TFIID subunit 4
Gene Symbol
TAF4
Additional Taf4 Products
Product Specific Notices for Taf4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...